In a recent study by Sun et al., a real-time assay for highly sensitive, label-free, multiplexed electrochemical SERS identification of stroke biomarkers, specifically neuron-specific enolase (NSE) and S100-β protein, was developed using a lateral flow device [13]. This evidence concerns the gene ENO2 and stroke disorder.